Skip to main content
VCbacked
Log inGet Started

EpiEndo Pharmaceuticals

Reykjavík, Iceland

EpiEndo Pharmaceuticals is a clinical biopharmaceutical company focused on novel solutions for chronic airway diseases.

$23.4M raised
Aug 2021
Series A
BiotechnologyHealth CareMedical

Top Investors

European Innovation CouncilBrunnur VenturesEISMEAFlerie InvestKvika Asset Management

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about EpiEndo Pharmaceuticals

How much funding has EpiEndo Pharmaceuticals raised?
EpiEndo Pharmaceuticals has raised $23.4M in total funding. The most recent round was Series A. The last funding was announced in August 2021.
Who are EpiEndo Pharmaceuticals's investors?
EpiEndo Pharmaceuticals's investors include European Innovation Council, Brunnur Ventures, EISMEA, Flerie Invest, Kvika Asset Management.
Where is EpiEndo Pharmaceuticals headquartered?
EpiEndo Pharmaceuticals is headquartered in Reykjavík, Iceland.
What does EpiEndo Pharmaceuticals do?
EpiEndo Pharmaceuticals is a clinical biopharmaceutical company focused on novel solutions for chronic airway diseases.
What stage is EpiEndo Pharmaceuticals at?
EpiEndo Pharmaceuticals is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"EpiEndo Pharmaceuticals — Funding & Investors." VCBacked, August 18, 2021, https://www.vcbacked.co/company/epiendo-pharmaceuticals. Accessed July 8, 2026.
APA
VCBacked. (2021). EpiEndo Pharmaceuticals — Funding & Investors. Retrieved July 8, 2026, from https://www.vcbacked.co/company/epiendo-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=EpiEndo Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/epiendo-pharmaceuticals |website=VCBacked |access-date=July 8, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
Renaissance BioScience
Vancouver$599K
AlpalifeBio
Woburn$9.8M
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K